Get the Stockscreener App
6.2733
7.97%
0.4633
Alpha Cognition Inc stock is traded at $6.2733, with a volume of 119.56K.
It is up +7.97% in the last 24 hours and up +8.16% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$5.81
Open:
$5.81
24h Volume:
119.56K
Relative Volume:
1.22
Market Cap:
$136.39M
Revenue:
-
Net Income/Loss:
$-14.72M
P/E Ratio:
-2.2167
EPS:
-2.83
Net Cash Flow:
$-7.41M
1W Performance:
+3.01%
1M Performance:
+8.16%
6M Performance:
-34.48%
1Y Performance:
+9.21%
1-Day Range:
$5.805
$6.49
1-Week Range:
$5.65
$6.49
52-Week Range:
$3.75
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1200-750 W PENDER ST, VANCOUVER
Compare ACOG with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
6.2733 | 126.32M | 0 | -14.72M | -7.41M | -2.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition to Participate in Virtual Fireside Chat Hosted by Titan Partners - Business Wire
Is Alpha Cognition Inc a good long term investmentGap Fill Strategies & Free Unstoppable Trading Performance - earlytimes.in
Why Alpha Cognition Inc. stock could rally in 2025July 2025 Retail & Consistent Profit Trading Strategies - BỘ NỘI VỤ
Alpha Cognition FY2025 EPS Estimate Cut by HC Wainwright - Defense World
Alpha Cognition Inc. $ACOG Shares Sold by Aristides Capital LLC - Defense World
Contrasting Sorrento Therapeutics (NASDAQ:SRNE) & Alpha Cognition (OTC:ACOGF) - Defense World
Alpha Cognition stock shows strong growth as H.C. Wainwright reiterates Buy rating - Investing.com Australia
Alpha Cognition Inc. Common Stock (NASDAQ:ACOG) Q1 2025 Earnings Call Transcript - MSN
Alpha Cognition Inc.Common Stock (NQ: ACOG - Markets Financial Content
Can Alpha Cognition Inc. stock deliver strong Q4 earningsJuly 2025 News Drivers & Expert Approved Momentum Trade Ideas - newser.com
Is Alpha Cognition Inc. (ACOG) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Alpha Cognition prices $35M public offering of common shares - MSN
Alpha Cognition Reports Accelerating ZUNVEYL Adoption in Long-Term Care Facilities - citybuzz
Will Alpha Cognition Inc. stock recover faster than market2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Will Alpha Cognition Inc. stock outperform growth indexes2025 Big Picture & Verified Entry Point Signals - newser.com
Here's Why We're Not Too Worried About Alpha Cognition's (NASDAQ:ACOG) Cash Burn Situation - Yahoo Finance
Custom watchlist performance reports with Alpha Cognition Inc.Entry Point & High Accuracy Swing Trade Signals - newser.com
Can Alpha Cognition Inc. recover in the next quarter2025 Key Highlights & Smart Swing Trading Alerts - newser.com
Can Alpha Cognition Inc. stock surprise with earnings upsideCEO Change & Fast Momentum Entry Tips - newser.com
Alpha Cognition’s Earnings Call: Strong Sales and Strategic Growth - MSN
Is Alpha Cognition Inc. stock attractive for long term wealth buildingQuarterly Market Review & Step-by-Step Trade Execution Guides - newser.com
Alpha Cognition (NASDAQ:ACOG) Stock Rating Upgraded by Wall Street Zen - Defense World
Alpha Cognition Inc. Reports Third Quarter 2025 Financial Results and Provides Operational Update - BioSpace
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q3 2025 - TradingView
Alpha Cognition (NASDAQ: ACOG) reports ZUNVEYL in 600+ nursing homes, 500+ prescribers - Stock Titan
Alpha Cognition Inc. Reports Q3 2025 Earnings and Strategic Progress - TipRanks
Alpha Cognition Inc. (ACOG) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com
Earnings call transcript: Alpha Cognition’s Q3 2025 reveals strategic growth By Investing.com - Investing.com Nigeria
ACOG: Q3 revenue up 102% in pharmacy orders, cash boosted to $73.2M after capital raise - TradingView
Earnings call transcript: Alpha Cognition’s Q3 2025 reveals strategic growth - Investing.com
Alpha Cognition Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
Alpha Cognition Inc. (ACOG) Q3 FY2025 earnings call transcript - Yahoo Finance
Alpha Cognition Inc Stock Analysis and ForecastStock Rotation Strategies & Use Our Sector Rotation Strategy for Gains - earlytimes.in
Earnings Scheduled For November 13, 2025 - Benzinga
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):